2024
Recanalization is the mainstay of ischemic stroke treatment. However, even with timely clot removal, many stroke patients recover poorly. Leptomeningeal (…)
Consulter
2024
Tissue-plasminogen activator (tPA) is a serine protease well known for its fibrinolytic function. Recent studies indicate that tPA could also (…)
Consulter
2024
There are several cellular and acellular structural barriers associated with the brain interfaces, which include the dura, the leptomeninges, the (…)
Consulter
2024
Consulter
2024
Intravenous injection of alteplase, a recombinant tPA (tissue-type plasminogen activator) as a thrombolytic agent has revolutionized ischemic stroke management. However, (…)
Consulter
2024
The pharmacological intervention for ischemic stroke hinges on intravenous administration of the recombinant tissue-type plasminogen activator (rtPA, Alteplase/Actilyse®) either as (…)
Consulter